Glenmark Pharmaceuticals on Monday announced that it has received final approval by the United States Food & Drug Administration (USFDA) for its lacosamide tablets.
The companys board on Friday (18 March) declared an interim dividend of Rs 3.75 per share.
Wockhardt announced a collaboration with Serum Life Sciences UK Ltd, a subsidiary of the Serum Institute of India, to deliver a global vaccine programme.
Atul rose 2.27% to Rs 9933.60 after the company said its board will consider a share buyback on 25 March 2022.
Zydus Lifesciences (formerly known as Cadila Healthcare) has received Prior Approval Supplement (PAS) approval from the USFDA to market Mycophenolate Mofetil for Injection USP, 500 mg/vial (US RLD: CellCept injection). The injection will be manufactured at the groups injectables manufacturing facility at Jarod near Vadodara in Gujarat. The Prior Approval Supplement (PAS) was for a site transfer into the Jarod site. This site was recently […]
The domestic equity barometers traded with modest losses in early trade. The Nifty as trading below the 17,300 mark. Metals, IT and healthcare stocks advanced while FMCG, banks and financials shares declined. At 09:21 IST, the barometer index, the S&P BSE Sensex, was down 72.01 points or 0.12% to 57,791.92. The Nifty 50 index lost 14.25 points or 0.08% to 17,272.80. Hindalco (up 3.69%), Maruti […]
The Indian rupee is expected to stay optimistic amid dollar weakness overseas on Monday, 21 March 2022, although rising crude oil prices could weigh down the domestic currency. On Thursday, rupee strengthened below Rs 76 per dollar mark. At the interbank forex market, the local unit opened at 75.96 against the greenback and witnessed an intra-day high of 75.77 and a low of 75.97. The […]
The interim dividend declared will be paid on or after April 05, 2022.
RRVL acquires 89% equity stake in Purple Panda Fashions, which owns and operates the Clovia business Founding team to continue to drive the business in the next phase of growth.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.